Recon: Lilly produces billions of weight-loss pills ahead of FDA approval; Philips gets FDA warning letter over issues at 3 facilities

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleUnited States